EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NFX1‐123: A potential therapeutic target in cervical cancer

Sreenivasulu Chintala, Maura A Dankoski, Anand Anbarasu iD, Sudha Ramaiah, Sravan Kumar Miryala, Rachel A Katzenellenbogen

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28856 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Sreenivasulu Chintala und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Oncogene Proteins, Viral. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NFX1‐123 is a splice variant isoform of the NFX1 gene. It is highly expressed in cervical cancers caused by HPV, and NFX1‐123 is a protein partner with the HPV oncoprotein E6. Together, NFX1‐123 and E6 affect cellular growth, longevity, and differentiation. The expression status of NFX1‐123 in cancers beyond cervical and head and neck cancers, and its potential as therapeutic target, have not been investigated. TSVdb of TCGA was used to quantify NFX1‐123 expression in 24 cancers compared with normal tissues. The NFX1‐123 protein structure was predicted and then submitted to retrieve suitable drug molecules. The top four compounds, found to bind in silico to NFX1‐123, were tested experimentally to determine their effects on NFX1‐123‐related cellular growth, survival, and migration. 46% of cancers (11 of 24 had significant differences in NFX1‐123 expression, with nine having had greater NFX1‐123 expression, when compared with adjacent normal tissues. Bioinformatics and proteomic predictive analysis modeled the three‐dimensional structure of NFX1‐123, and drug libraries were screened for high‐binding affinity compounds using this modeled structure. Seventeen drugs with binding energies ranging from −1.3 to −10 Kcal/mol were identified. The top four compounds were used to treat HPV‐ and HPV+ cervical cancer cell lines, three of which (Ropitoin, R428 and Ketoconazole) reduced NFX1‐123 protein levels, inhibited cellular growth, survival, and migration, and enhanced the cytotoxicity of Cisplatin. These findings highlight cancers expressing high levels of NFX1‐123, and drugs that target it, may reduce cellular growth, survival, and migration, making NFX1‐123 a potential novel therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsOncogene Proteins, ViralFemaleHumansRepressor ProteinsProteomicsCell Line

Stichwörter der Autor:innen

computer modelinghuman papillomavirusoncogenesisrational drug design

Substanzen

Repressor ProteinsOncogene Proteins, ViralNFX1 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Medical & Biological Computing Laboratory, School of Bio-Sciences & Technology, Vellore Institute of Technology, Vellore, India.

ORCID-Profile: Anand Anbarasu

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Chintala, S., Dankoski, M. A., Anbarasu, A., Ramaiah, S., Miryala, S. K., & Katzenellenbogen, R. A. (2023). NFX1‐123: A potential therapeutic target in cervical cancer. Journal of Medical Virology. https://doi.org/10.1002/jmv.28856

Vancouver

Chintala S, Dankoski MA, Anbarasu A, Ramaiah S, Miryala SK, Katzenellenbogen RA. NFX1‐123: A potential therapeutic target in cervical cancer. Journal of Medical Virology. 2023. doi:10.1002/jmv.28856

BibTeX
@article{Chintala2023,
  author = {Chintala, Sreenivasulu and Dankoski, Maura A and Anbarasu, Anand and Ramaiah, Sudha and Miryala, Sravan Kumar and Katzenellenbogen, Rachel A},
  title = {NFX1‐123: A potential therapeutic target in cervical cancer},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28856}
}
Kostenlos starten →